Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study of an Investigational Study Drug for Benign Prostatic Hyperplasia (0906-140)
This study has been completed.
Study NCT00127179 Information provided by Merck Sharp & Dohme Corp.
First Received on August 3, 2005. Last Updated on July 22, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Benign Prostatic Hyperplasia
Additional conditions recognized in this trial
More general conditions related to this trial
Genital Diseases, Male
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
5-alpha Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers